Abstract
Bleeding and thrombosis are major causes of morbidity and mortality in patients with chronic myeloproliferative disorders. We retrospectively evaluated 101 consecutive patients affected by primary thrombocytosis (46 male, 55 female, aged 18-84 years; mean +/- SD 61 +/- 15) followed for a period ranging from 6 months up to 10 years (median 5 years) at our hematological unit. At the time of diagnosis 48 patients were asymptomatic; 26 had clinical evidence of atherothrombosis (cerebral ischemic attacks, ischemic heart disease, peripheral occlusive arterial disease), ten had venous thrombosis, four experienced major hemorrhages, 23 presented microvascular ischemic manifestations namely erythromelalgia, paresthesias, acrocyanosis and dizziness. At presentation 51.2% of the patients had elevated serum lactic dehydrogenase, 34.5% hyperuricemia, and 23.4% serum creatinine > 1.2 mg/dL. Color Doppler ultrasound provided evidence of vascular stenosis or medium-intimal hyperplasia of epiaortic vessels in 48.9% of patients studied, and similar alterations of lower limb arteries in 23.8% of cases. Therapy modality included an antiplatelet agent (picotamide 300 mg/bid); a cytoreductive agent (busulphan, hydroxyurea, pipobroman or melphalan) w...Continue Reading
References
Aug 1, 1977·British Journal of Haematology·A K Singh, G Wetherley-Mein
Jul 1, 1978·American Heart Journal·S HussainS N Chua
Oct 21, 1976·The New England Journal of Medicine·J W AdamsonL Steinmann
Jul 1, 1975·The Journal of Pediatrics·J M FallettaC L Sexauer
Feb 1, 1991·Mayo Clinic Proceedings·K J McIntyreR M Petitt
Jun 1, 1991·Cancer·M ColombiA T Maiolo
Jun 1, 1991·British Journal of Haematology·T C Pearson
Aug 1, 1990·Cancer·P FenauxF Bauters
Jan 1, 1987·Acta Haematologica·M L RandiA Girolami
May 19, 1988·The New England Journal of Medicine·M N SilversteinL P Schacter
Jun 15, 1988·Cancer·R HehlmannW Köpcke
Dec 1, 1986·Cancer·S BellucciM Boiron
Feb 1, 1986·British Journal of Haematology·J E Van de PetteG Wetherley-Mein
Apr 1, 1985·Annals of Internal Medicine·J J MichielsV D Vuzevski
Aug 31, 1974·British Medical Journal·F E PrestonR G Malia
Nov 1, 1983·European Journal of Cancer & Clinical Oncology·T BarbuiN Semeraro
Oct 1, 1983·Annals of Internal Medicine·J JabailyA V Pisciotta
Feb 18, 1982·The New England Journal of Medicine·A I Schafer
Jan 1, 1982·British Journal of Haematology·C M KesslerR J Havlik
Apr 27, 1995·The New England Journal of Medicine·S CortelazzoT Barbui
Jun 1, 1993·Neurology·J J MichielsH H van Vliet
Feb 15, 1993·Cancer·J E NaschitzL M Lev
Feb 1, 1993·British Journal of Haematology·K V Watson, N Key
Jan 31, 2006·Clinical and Applied Thrombosis/hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis·Viroj Wiwanitkit
Jan 16, 2007·Internal and Emergency Medicine·Walter Ageno, Alessandro Squizzato
Jan 1, 1991·Leukemia & Lymphoma·A HattoriA Shibata
Citations
May 15, 1997·Cancer·W D FiggE Reed
Oct 5, 2001·Clinical Neuropharmacology·R J DumontA S Dumont
Oct 5, 2001·Clinical Neuropharmacology·R J DumontA S Dumont
Jan 1, 2009·BMJ Case Reports·Jyothi KondlapudiSamantha Mawer
Mar 24, 2011·Vascular Medicine·Andrew K KurklinskyThom W Rooke
Oct 2, 2004·International Journal of Cardiology·Gurhan KadikoyluZahit Bolaman
Mar 1, 2006·Transfusion and Apheresis Science : Official Journal of the World Apheresis Association : Official Journal of the European Society for Haemapheresis·Irfan YavasogluZahit Bolaman